We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Treatment of advanced cutaneous T-cell lymphomas with non-pegylated liposomal doxorubicin--consensus of the lymphoma group of the Working Group Dermatologic Oncology.
- Authors
Assaf, Chalid; Becker, Jürgen C; Beyer, Marc; Cozzio, Antonio; Dippel, Edgar; Klemke, Claus-Detlev; Kurschat, Peter; Weichenthal, Michael; Stadler, Rudolf
- Abstract
Systemic treatment with pegylated liposomal doxorubicin is an established second-line treatment of advanced cutaneous T-cell lymphoma. Pegylated liposomal doxorubicin (PLD) is currently unavailable, therefore, clinical studies investigating the efficacy of non-pegylated liposomal formula (NPLD) have been analyzed.
- Publication
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2013, Vol 11, Issue 4, p338
- ISSN
1610-0387
- Publication type
Journal Article
- DOI
10.1111/ddg.12012